Japan’s Bio Search announced on November 9, 2026 that it had signed a share-exchange agreement to acquire 100% of InnerEye, an Israeli company developing AI that analyzes brain signals in real time. The transaction would make InnerEye a wholly owned subsidiary and add its expert-decision technology to Bio Search’s healthcare AI business. Completion has not yet occurred. Closing remains subject to customary conditions, including approvals from relevant Israeli authorities, and is scheduled…